Germany TED / Vergabe.de contract award · ocds-ted-154179-2024
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs
DAK-Gesundheit awarded €1 to BeiGene Germany GmbH for Healthcare & Medical in March 2024 — one of 389 awards this buyer has made, in line with its typical award size.
14 Mar 2024
Award date
€1
Contract value
Buying agency
DAK-Gesundheit 389 Awards
€581K Avg award
Typical vs typical
Winning supplier
BeiGene Germany GmbH 1 Award
1 Buyer
€1 Total won
Contract description
Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 des Fünften Sozialgesetzbuchs - Brukinsa (Wirkstoff: Zanubrutinib), ATC L01EL03
Premium
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Tender no.SupplierAmountDateSector
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and BeiGene Germany GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back